American Shared Hospital Services ( AMS ) Q3 2025 Earnings Call November 13, 2025 1:00 PM EST Company Participants Raymond Stachowiak - Executive Chairman Gary Delanois - Chief Executive Officer Frech Scott - Chief Financial Officer Conference Call Participants Kirin Smith - ProActive Capital Group, LLC Tony Kamin Anthony Marchese Presentation Operator Good day, and welcome to the American Shared Hospital Services Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Third Quarter Revenue Increased 2.5% Period over Period with 42.3% EBITDA Growth Revenue for the First Nine Months Increased 5.
Call Scheduled for November 13th at 1:00 PM ET SAN FRANCISCO, November 6, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient
| Health Care Providers & Services Industry | Healthcare Sector | Gary Delanois CEO | CNSX Exchange | US0295951059 ISIN |
| US Country | 81 Employees | 16 Jul 2007 Last Dividend | - Last Split | 7 Sep 1984 IPO Date |
American Shared Hospital Services (ASHS) is a company specialized in providing cutting-edge stereotactic radiosurgery and advanced radiation therapy equipment to healthcare facilities. Founded in 1980 and headquartered in San Francisco, California, ASHS primarily engages in the leasing of medical equipment and offering comprehensive services including planning, installation, reimbursement, and marketing support to its clients. The company operates through two main segments: Medical Equipment Leasing and Retail, catering to a global market that includes cancer treatment centers, hospitals, and cancer networks.
This is a non-invasive treatment method for both malignant and benign brain tumors, as well as arteriovenous malformations and trigeminal neuralgia. ASHS provides radiosurgery equipment that facilitates this precise form of radiation therapy, which targets only the affected areas, sparing the surrounding healthy tissue.
In addition to supplying the equipment for Gamma Knife radiosurgery, ASHS offers financing solutions to healthcare institutions seeking to acquire Leksell Gamma Knife units. This service ensures more facilities can access this advanced treatment technology without facing prohibitive upfront costs.
ASHS’s core business includes the leasing of a wide range of medical equipment, beyond the Gamma Knife systems. This allows hospitals and treatment centers to equip themselves with the latest technology in radiation therapy without bearing the full cost of purchasing these expensive machines outright.
Offered in Orlando, Florida, and Long Beach, California, ASHS expands its radiation therapy services to include proton beam therapy—an advanced form of radiation therapy that uses protons rather than X-rays to treat cancer. Proton therapy is known for its precision and reduced side effects, making it a preferred option for treating certain types of cancer.
To ensure the effective utilization of its leased equipment, ASHS provides a suite of support services. These include assistance with planning and installation of the equipment, navigation of reimbursement processes, and marketing support to help its clients effectively promote their new capabilities to patients and referring physicians.